BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23762406)

  • 1. HIV drug resistance early warning indicators in Namibia for public health action.
    Jonas A; Gweshe J; Siboleka M; Deklerk M; Gawanab M; Badi A; Sumbi V; Pereko D; Blom A; Mwinga S; Jordan MR; Jerger L; Lau K; Hong SY
    PLoS One; 2013; 8(6):e65653. PubMed ID: 23762406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.
    Hong SY; Jonas A; Dumeni E; Badi A; Pereko D; Blom A; Muthiani VS; Shiningavamwe AN; Mukamba J; Andemichael G; Barbara R; Bennett DE; Jordan MR
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):27-31. PubMed ID: 20838224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
    Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
    PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
    Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
    BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
    Billong SC; Fokam J; Nkwescheu AS; Kembou E; Milenge P; Tsomo Z; Dion GN; Aghokeng AF; Mpoudi EN; Ndumbe PM; Colizzi V; Elat Nfetam JB
    PLoS One; 2012; 7(5):e36777. PubMed ID: 22615810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.
    Jonas A; Sumbi V; Mwinga S; DeKlerk M; Tjituka F; Penney S; Jordan MR; Desta T; Tang AM; Hong SY
    PLoS One; 2014; 9(7):e100539. PubMed ID: 24988387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
    HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
    Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
    PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
    Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
    Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.
    Fokam J; Elat JB; Billong SC; Kembou E; Nkwescheu AS; Obam NM; Essiane A; Torimiro JN; Ekanmian GK; Ndjolo A; Shiro KS; Bissek AC
    PLoS One; 2015; 10(6):e0129210. PubMed ID: 26083364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
    Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
    Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
    Dzangare J; Gonese E; Mugurungi O; Shamu T; Apollo T; Bennett DE; Kelley KF; Jordan MR; Chakanyuka C; Cham F; Banda RM
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S313-6. PubMed ID: 22544194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.
    Hong SY; Jonas A; DeKlerk M; Shiningavamwe A; Desta T; Badi A; Morris L; Hunt GM; Ledwaba J; Sheehan HB; Lau K; Trotter A; Tang AM; Wanke C; Jordan MR
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):463-71. PubMed ID: 25564107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.
    Bennett DE; Jordan MR; Bertagnolio S; Hong SY; Ravasi G; McMahon JH; Saadani A; Kelley KF
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S280-9. PubMed ID: 22544188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.
    Juma JM; Tiberio JK; Abuya MI; Kilama BK; Somi GR; Sambu V; Banda R; Jullu BS; Ramadhani AA
    BMC Infect Dis; 2014 Apr; 14():196. PubMed ID: 24725750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of early warning indicators of HIV resistance to antiretroviral (ARV) drugs in Ivory Coast in 2011].
    Yao KJ; Damey NF; Konan DJ; Aka J; Aka-Konan S; Ani A; Bonle MT; Kouassi D
    Pan Afr Med J; 2016; 25():52. PubMed ID: 28250876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
    Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
    Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early warning indicators for HIV drug resistance in Malawi.
    Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
    Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment HIV drug resistance among adults initiating ART in Namibia.
    Taffa N; Roscoe C; Sawadogo S; De Klerk M; Baughman AL; Wolkon A; Mutenda N; DeVos J; Zheng DP; Wagar N; Prybylski D; Yang C; Hamunime N; Agolory S; Raizes E
    J Antimicrob Chemother; 2018 Nov; 73(11):3137-3142. PubMed ID: 30137412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.